These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14760498)

  • 1. Insulin-like growth factor-1 expression in reflux nephropathy.
    Chertin B; Farkas A; Puri P
    Pediatr Surg Int; 2004 Apr; 20(4):283-9. PubMed ID: 14760498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor and monocyte chemotactic peptide-1 expression in reflux nephropathy.
    Chertin B; Farkas A; Puri P
    Eur Urol; 2003 Jul; 44(1):144-9. PubMed ID: 12814691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nitric oxide in reflux nephropathy.
    Chertin B; Rolle U; Farkas A; Puri P
    Pediatr Surg Int; 2002 Oct; 18(7):630-4. PubMed ID: 12471480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of angiotensin-converting enzyme (ACE) gene expression induces tubulointerstitial injury in reflux nephropathy.
    Chertin B; Solari V; Reen DJ; Farkas A; Puri P
    Pediatr Surg Int; 2002 Oct; 18(7):635-9. PubMed ID: 12471481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAM-1 expression is upregulated in reflux nephropathy.
    Unemoto K; Chertin B; Shima H; Bi X; Sakai M; Puri P
    Pediatr Surg Int; 2003 Jul; 19(5):391-4. PubMed ID: 12759765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of angiotensin II receptors in reflux nephropathy.
    Chertin B; Rolle U; Cascio S; McDermot M; O'Briain S; Farkas A; Puri P
    J Pediatr Surg; 2002 Feb; 37(2):251-5. PubMed ID: 11819209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide, enhanced by macrophage-colony stimulating factor, mediates renal damage in reflux nephropathy.
    Rolle U; Shima H; Puri P
    Kidney Int; 2002 Aug; 62(2):507-13. PubMed ID: 12110011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 up-regulation in reflux nephropathy.
    Solari V; Piotrowska AP; Cascio S; Unemoto K; Chertin B; Puri P
    J Urol; 2003 Oct; 170(4 Pt 2):1624-7. PubMed ID: 14501677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of mast cells in reflux nephropathy.
    Solari V; Unemoto K; Piaseczna Piotrowska A; Puri P
    Pediatr Nephrol; 2004 Feb; 19(2):157-63. PubMed ID: 14677055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery following relief of unilateral ureteral obstruction in the neonatal rat.
    Chevalier RL; Kim A; Thornhill BA; Wolstenholme JT
    Kidney Int; 1999 Mar; 55(3):793-807. PubMed ID: 10027917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor.
    Chevalier RL; Goyal S; Wolstenholme JT; Thornhill BA
    Kidney Int; 1998 Jul; 54(1):38-47. PubMed ID: 9648061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway.
    Kong YL; Shen Y; Ni J; Shao DC; Miao NJ; Xu JL; Zhou L; Xue H; Zhang W; Wang XX; Lu LM
    Acta Pharmacol Sin; 2016 Feb; 37(2):217-27. PubMed ID: 26775660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1.
    Chevalier RL; Goyal S; Kim A; Chang AY; Landau D; LeRoith D
    Kidney Int; 2000 Mar; 57(3):882-90. PubMed ID: 10720941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque.
    Okura Y; Brink M; Zahid AA; Anwar A; Delafontaine P
    J Mol Cell Cardiol; 2001 Oct; 33(10):1777-89. PubMed ID: 11603921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1/IGF-1R blockade ameliorates diabetic kidney disease through normalizing Snail1 expression in a mouse model.
    Dong R; Yu J; Yu F; Yang S; Qian Q; Zha Y
    Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E686-E698. PubMed ID: 31361542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy.
    Oldroyd SD; Miyamoto Y; Moir A; Johnson TS; El Nahas AM; Haylor JL
    Am J Physiol Renal Physiol; 2006 Mar; 290(3):F695-702. PubMed ID: 16204415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II and IGF-I may interact to regulate tubulointerstitial cell kinetics and phenotypic changes in hypertensive rats.
    Kobayashi S; Moriya H; Nakabayashi I; Nishiyama J; Fukuda T
    Hypertens Res; 2002 Mar; 25(2):257-69. PubMed ID: 12047042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 1 (IGF-1) and its receptor mRNA levels in breast cancer and adjacent non-neoplastic tissue.
    Chong YM; Williams SL; Elkak A; Sharma AK; Mokbel K
    Anticancer Res; 2006; 26(1A):167-73. PubMed ID: 16475694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia.
    Tönshoff B; Powell DR; Zhao D; Durham SK; Coleman ME; Domené HM; Blum WF; Baxter RC; Moore LC; Kaskel FJ
    Endocrinology; 1997 Mar; 138(3):938-46. PubMed ID: 9048593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.